DNA — Ginkgo Bioworks Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Ginkgo Bioworks Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	381	1,550	1,316	944	562
Net Total Accounts Receivable
Net Total Receivables	24.2	150	84	31.7	22.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	427	1,723	1,450	1,002	603
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	121	146	716	397	598
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	675	2,071	2,539	1,665	1,377
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.2	135	173	164	107
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	214	566	803	568	661
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	461	1,505	1,736	1,097	716
Total Liabilities & Shareholders' Equity	675	2,071	2,539	1,665	1,377
Total Common Shares Outstanding